Close

Analyst Ratings for Magenta Therapeutics (MGTA) [Buys]

MGTA Rating Summary

  |   Expand Research on MGTA
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10   Percentile Rank: 53%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/28/2023 H.C. Wainwright Edward White New Coverage Buy
(N/A)
N/A
(N/A)
0.81
(0.70)
-13.58% Details
12/2/2021 Mizuho
» Updated 4/18/2022
Vamil Divan New Coverage Buy
(N/A)
8.00
(17.00)
5.63
(0.70)
-87.57% Details